Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton Complete

Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
By Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton
Complete

,Chapter 01: Drug Definitions, Standards, and Information Sources Willihnga
ws ws ws ws ws ws ws ws


nz: Clayton’s Basic Pharmacology for Nurses, 19th Edition
ws ws ws ws ws ws ws




MULTIPLE CHOICE ws




1. Which name identifies a drug listed by the US Food a
ws ws ws ws ws ws ws ws ws ws


nd Drug Administration (FDA)?
ws ws ws


a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C ws


The official name is the name under which a drug is list
ws ws ws ws w s ws ws ws ws ws ws


ed by the FDA. The brand name, or trademark, is the na
ws ws ws ws ws ws ws ws ws ws ws


me given to a drug by its manufacturer. The nonproprieta
ws ws ws ws ws ws ws ws ws


ry, or generic, name is provided by the United States Ado
ws ws ws ws ws ws ws ws ws ws


pted Names Council.
ws ws




DIF: Cognitive Level: Knowledge REF: p. 9 ws ws ws ws


OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective C
ws ws ws ws ws ws ws ws


are Environment TOP: Nursing Process Step: Assessment
ws ws w s ws ws ws


CON: ws


Patient Education ws




2. Which source contains information specific to nutritional supplements?
ws ws ws ws ws ws ws


a. USP Dictionary of USAN & International Drug Names
ws ws ws ws ws ws ws


b. Natural Medicines Comprehensive Database ws ws ws


c. United States Pharmacopoeia/National Formulary (USP NF)
ws ws ws ws ws


d. Drug Interaction Facts ws ws




ANS: C ws


United States Pharmacopoeia/National Formulary contains information specific to nutrition
ws ws ws ws ws ws ws ws


al supplements. USP Dictionary of USAN & International Drug Names is a compilation of
ws ws ws ws ws ws ws ws ws ws ws ws ws


drug names, pronunciation guide, and possible future FDA approved drugs; it does not in
ws ws ws ws ws ws ws ws ws ws ws ws ws ws


clude nutritional supplements. Natural Medicines Comprehensive Database contains
ws ws ws ws ws ws ws


evidence-
based information on herbal medicines and herbal combination products; it does not include
ws ws ws ws ws ws ws ws ws ws ws ws


information specific to nutritional supplements. Drug Interaction Facts contains compreh
ws ws ws ws ws ws ws ws ws ws


ensive information on drug interaction facts; it does not include nutritional supplements.
ws ws ws ws ws ws ws ws ws ws ws




DIF: Cognitive Level: Knowledge REF: p. 4 ws ws w s ws


OBJ: 3 NAT: NCLEX Client Needs Category: Physiological I
ws ws w s ws ws ws ws ws


ntegrity
TOP: Nursing Process Step: Assessment CON: Nutrition | Patient Education
w s ws ws ws ws ws ws ws




3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
ws ws ws ws ws ws ws ws ws ws ws ws ws


a. Drug Facts and Comparisons ws ws ws

,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Editi
ws ws ws ws ws ws ws ws ws 3
on
b. Drug Interaction Facts ws ws


c. Handbook on Injectable Drugs ws ws ws


d. Martindale—The Complete Drug Reference ws ws ws




ANS: A ws


Drug Facts and Comparisons contains drug monographs that describe all drugs in
ws ws ws ws ws ws ws ws ws ws ws w


a therapeutic class. Monographs are formatted as tables to allow comparison of simi
s ws ws ws ws ws ws ws ws ws ws ws ws


lar products, brand names, manufacturers, cost indices, and available dosage form
ws ws ws ws ws ws ws ws ws ws


s Online version is available.
ws ws ws ws




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 ws ws w s ws ws ws


OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w s w s ws ws ws ws ws ws


TOP: Nursing Process Step: Assessment CON: Safety | Patient Education | Clinical Judgment
w s ws ws ws ws ws ws ws ws ws ws




4. Which drug reference contains monographs about virtually every single-
ws ws ws ws ws ws ws ws


entity drug available in the United States and describes therapeutic uses of drugs, includi
ws ws ws ws ws ws ws ws ws ws ws ws ws


ng approved and unapproved uses?
ws ws ws ws


a. Martindale: The Complete Drug Reference ws ws ws ws


b. AHFS Drug Information ws ws


c. Drug Reference ws


d. Drug Facts and Comparisons ws ws ws




ANS: B ws


AHFS Drug Information contains monographs about virtually every single-
ws ws ws ws ws ws ws ws


entity drug available in the United States and describes therapeutic uses of drugs, including
ws ws ws ws ws ws ws ws ws ws ws ws ws ws


approved and unapproved uses. ws ws ws




DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 ws ws w s ws ws ws


OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
w s w s ws ws ws ws ws ws


TOP: Nursing Process Step: Planning
w s CON: Safety | Patient Education | Clinical Judgment
ws ws ws ws ws ws ws ws ws ws




5. Which online drug reference makes available to healthcare providers and the public a
ws ws ws ws ws ws ws ws ws ws ws ws ws


standard, comprehensive, up-to- ws ws


date look up and downloadable resource about medicines?
ws ws ws ws ws ws ws


a. American Drug Index ws ws


b. American Hospital Formulary ws ws


c. DailyMed
d. Drug Reference ws




ANS: C ws


DailyMed makes available to healthcare providers and the public a standard, comprehensi
ws ws ws ws ws ws ws ws ws ws ws


ve, up-to- ws


date look up and downloadable resource about medicines. The American Drug Index is not
ws ws ws ws ws ws ws ws ws ws ws ws ws


appropriate for patient use. The American Hospital Formulary is not appropriate for pat
ws ws ws ws ws ws ws ws ws ws ws ws ws


ient use. The drug reference is not appropriate for patient use.
ws ws ws ws ws ws ws ws ws ws




DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 ws ws w s ws ws ws ws


OBJ: 3 NAT: NCLEX Client Needs Category: Physiological I
ws ws w s ws ws ws ws ws


ntegrity
TOP: Nursing Process Step: Implementation
ws ws ws ws


CON: Safety | Patient Education | Clinical Judgment
ws ws ws ws ws ws ws




6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
ws ws ws ws ws ws ws ws ws ws ws ws ws ws


a. Federal Food, Drug, and Cosmetic Act (1938)
ws ws ws ws ws ws


b. Durham Humphrey Amendment (1952) ws ws ws

, Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Editi
ws ws ws ws ws ws ws ws ws 4
on
c. Controlled Substances Act (1970) ws ws ws


d. Kefauver Harris Drug Amendment (1962) ws ws ws ws




ANS: A ws


The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the
ws ws ws ws ws ws ws ws ws ws ws ws ws ws w


safety of all drugs before marketing. Later amendments and acts helped tighten FDA cont
s ws ws ws ws ws ws ws ws ws ws ws ws ws


rol and ensure drug safety. The Durham Humphrey Amendment defines the kinds of drug
ws ws ws ws ws ws ws ws ws ws ws ws ws


s that cannot be used safely without medical supervision and restricts their sale to prescri
ws ws ws ws ws ws ws ws ws ws ws ws ws ws


ption by a licensed practitioner. The Controlled Substances Act addresses only controlled s
ws ws ws ws ws ws ws ws ws ws ws ws


ubstances and their categorization. The Kefauver Harris Drug Amendment ensures drug eff
ws ws ws ws ws ws ws ws ws ws ws


icacy and greater drug safety. Drug manufacturers are required to prove to the FDA the e
ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws


ffectiveness of their products before marketing them. ws ws ws ws ws ws




DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 ws ws w s ws ws ws


OBJ: 5 w s


NAT: NCLEX Client Needs Category: Physiological Integri ws ws ws ws ws ws


ty TOP: Nursing Process Step: Assessment
ws w s ws ws ws


CON: Safety | Patient Education | Evidence | Health Care Law
ws ws ws ws ws ws ws ws ws ws




7. Which classification does meperidine (Demerol) fall under?
ws ws ws ws ws ws


a. I
b. II
c. III
d. IV
ANS: B ws


Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lea
ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws


d to severe psychological and physical dependence. Schedule I drugs have high potential fo
ws ws ws ws ws ws ws ws ws ws ws ws ws


r abuse and no recognized medical use. Schedule III drugs have some potential for abuse.
ws ws ws ws ws ws ws ws ws ws ws ws ws ws


Use may lead to low to moderate physical dependence or high psychological dependence.
ws ws ws ws ws ws ws ws ws ws ws ws ws


Schedule IV drugs have low potential for abuse. Use may lead to limited physical or psy
ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws


chological dependence. ws




DIF: Cognitive Level: Knowledge REF: p. 10 ws ws w s ws


OBJ: 2 NAT: NCLEX Client Needs Category: Safe, Effective
ws ws ws ws ws ws ws ws ws


Care Environment ws


TOP: Nursing Process Step: Assessment CON: Patient Education | Addiction | Pain
w s ws ws ws ws ws ws ws ws ws




8. Which action would the FDA take to expedite drug development and approval for an outbr
ws ws ws ws ws ws ws ws ws ws ws ws ws ws


eak of smallpox?
ws ws


a. List smallpox as a health orphan disease.
ws ws ws ws ws ws


b. Omit the preclinical research phase. ws ws ws ws


c. Extend the clinical research phase. ws ws ws ws


d. Fast track the investigational drug.
ws ws ws ws




ANS: D ws


Once the Investigational New Drug Application has been approved, the drug can receive
ws ws ws ws ws ws ws ws ws ws ws ws ws


highest priority within the agency, which is called fast tracking. A smallpox outbreak wo
ws ws ws ws ws ws ws ws ws ws ws ws ws


uld become a priority concern in the world. Orphan diseases are not researched in a prior
ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws


ity manner. Preclinical research is not omitted. Extending any phase of the research woul
ws ws ws ws ws ws ws ws ws ws ws ws ws


d mean a longer time to develop a vaccine. The FDA must ensure that all phases of the pr
ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws ws


eclinical and clinical research phase have been completed in a safe manner.
ws ws ws ws ws ws ws ws ws ws ws




DIF: Cognitive Level: Knowledge ws ws REF: wsws p. 7 ws OBJ: 5 ws